Operating Lease, Right-of-Use Asset of NEOGENOMICS INC from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NEOGENOMICS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • NEOGENOMICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $80,150,000, a 1.6% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NEOGENOMICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $80,150,000 -$1,292,000 -1.6% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $82,870,000 -$801,000 -0.96% 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q1 2025 $77,803,000 -$8,775,000 -10% 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 $79,583,000 -$12,186,000 -13% 31 Dec 2024 10-Q 28 Oct 2025 2025 Q3
Q3 2024 $81,442,000 -$5,689,000 -6.5% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $83,671,000 -$7,741,000 -8.5% 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 $86,578,000 -$7,206,000 -7.7% 31 Mar 2024 10-Q 30 Apr 2024 2024 Q1
Q4 2023 $91,769,000 -$4,340,000 -4.5% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 $87,131,000 -$11,814,000 -12% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $91,412,000 -$8,505,000 -8.5% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $93,784,000 -$8,171,000 -8% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $96,109,000 -$6,088,000 -6% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $98,945,000 -$3,365,000 -3.3% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $99,917,000 +$45,359,000 +83% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $101,955,000 +$51,051,000 +100% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $102,197,000 +$56,411,000 +123% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 $102,310,000 +$56,454,000 +123% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $54,558,000 +$7,004,000 +15% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $50,904,000 +$1,820,000 +3.7% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $45,786,000 +$19,294,000 +73% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $45,856,000 +$20,059,000 +78% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $47,554,000 +$21,497,000 +82% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $49,084,000 +$29,350,000 +149% 31 Mar 2020 10-Q 29 Apr 2020 2020 Q1
Q4 2019 $26,492,000 +$16,792,000 +173% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $25,797,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $26,057,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $19,734,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $9,700,000 01 Jan 2019 10-K 28 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.